Skip to main content
. Author manuscript; available in PMC: 2018 Oct 1.
Published in final edited form as: Pediatr Crit Care Med. 2017 Oct;18(10):e446–e454. doi: 10.1097/PCC.0000000000001280

Table 4.

Expected AKIN Stage under Hypothetical Conditions

No. Baseline creatinine Time to ROSC (min) Chronic lung condition No. of epinephrine doses Probability of no AKI Probability of AKIN Stage 3
1 Normal 24.67 No 3 0.63747 0.08996
2 Normal 24.67 No 6 0.56018 0.12699
3 Normal 24.67 No 9 0.48051 0.17349
4 Normal 49.34 No 3 0.65447 0.08276
5 Normal 74.01 No 3 0.65995 0.08051
6 Abnormal 24.67 No 3 0.53583 0.14024
7 Normal 24.67 Yes 3 0.81198 0.03043
8 Abnormal 24.67 No 9 0.37804 0.24867